Levaquin
Company: R.W. Johnson
Approval Status: Approved July 1999
Treatment for: Urology
Areas: Nephrology/Urology
General Information
Levaquin has been approved for the treatment of uncomplicated urinary tract infections.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.





